Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Lottery grant will boost public art at UFS
2009-05-25

 
 Public art at the UFS will get a major boost with money made available by the National Lottery Board. Here are Dr Ivan van Rooyen, Director: UFS Marketing, Ms Nontombi Ntakakaze (Artists in School Project) and Mr Ben Botma (Head of Department: Fine Arts) at one of the existing works of art by Edoardo Villa on the Bloemfontein Campus. 
Photo: Leatitia Pienaar.
Emerging and established artists will showcase their work in a comprehensive public sculpture project on the campuses of the University of the Free State (UFS). The aim is to create a greater understanding of cultural differences and promote the UFS vision of a truly multilingual, non-sexist, non-racial campus, says Dr Ivan van Rooyen, Director: UFS Marketing.

The National Lottery Board has approved a grant of R4,125 million in total for three major projects, one of which is the public sculpture project. The others are a Khoe-San Early Learning Centre pilot project in Heidedal, and a boost for the Artists in Schools project, which is already underway.

Dr Van Rooyen says one way of promoting the UFS vision is to create an alternative environment and provide visible, tangible symbols of change and transformation. This will enrich the educational and cultural experience of students and visitors to the campus by stimulating intercultural dialogue and providing a setting for historical dialogue between past and future.

The dream of the UFS is to inspire a sense of ownership of the campus of an open university, worthy of a democratic South Africa. “Therefore, a large-scale project of national significance has been conceptualised, where the development of infrastructure will involve the creation and acquisition of major South African art works for the long-term benefit of all South Africans,” Dr Van Rooyen says.

The public sculpture project will be implemented over the next few years. Artists will be commissioned as funds become available. The UFS will also consult extensively with local and national art museums with experience in the public art field. A wide spectrum of artists, especially artists from the black community, will be used.

Dr Van Rooyen says that many black artists have not had an opportunity to exhibit public sculptures because of prohibitive costs and the project will empower them to develop their skills. The project makes provision for both established and emerging artists to showcase their work.

The aim of the Khoe-San Early Learning Centre pilot project is to compile a curriculum that is sensitive to multiculturalism and multilingualism. The centre will be the first in the country and will respond to the need to promote and revitalise Khoe-San languages. Using arts and crafts and storytelling, as well as literacy, numeracy and life skills, children will learn to adapt to their environment and contribute to our diverse society. This centre will be a collaborative venture between the Heidedal community and the UFS.

Finally, the Artists in Schools project, which has been running successfully since 2004, will also receive a boost from the Lottery funding. Through a series of workshops that the Department of Fine Arts presents at schools, participants develop functional art products with a distinctive Free State character. These products are marketed and sold to benefit the artists, designers and craftspeople.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt.stg@ufs.ac.za
25 May 2009
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept